Skip to content

HIFEM for Arms, Lower Limbs, and Oblique Muscles

Efficacy of HIFEM Treatments for Strengthening and Toning of Arms, Lower Limbs and Oblique Muscles

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04426526
Enrollment
23
Registered
2020-06-11
Start date
2019-05-08
Completion date
2020-12-08
Last updated
2021-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Tone Increased

Keywords

muscle strengthening, muscle tone

Brief summary

Evaluation of HIFEM treatments for strengthening and toning of arms, lower limbs and oblique muscles.

Detailed description

This study will evaluate the clinical efficacy and safety of the high power magnet system for toning and strengthening of arm, lower limb and oblique muscles. The study is a prospective multi-center open-label four-arm study.

Interventions

DEVICEBTL 799-2

High power magnet system

Sponsors

BTL Industries Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Voluntarily signed informed consent form * BMI ≤ 30 kg/m2 * Women of child-bearing potential are required to use birth control measures during the whole duration of the study * Subjects willing and able to abstain from partaking in any treatments other than the study procedure to promote body contouring during study participation * Subjects willing and able to maintain her regular (pre-procedure) diet and exercise regimen without effecting significant change in either direction during study participation

Exclusion criteria

* Cardiac pacemakers * Implanted defibrillators, implanted neurostimulators * Electronic implants * Pulmonary insufficiency * Metal implants * Drug pumps * Application in the head area * Application in the heart area * Malignant tumor * Injured or otherwise impaired muscles * Fever * Pregnancy * Sensitivity or allergy to latex * Breastfeeding * Following recent surgical procedures when muscle contraction may disrupt the healing process * Application over areas of the skin which lack normal sensation * Scars, open lesions and wounds at the treatment area * Unrepaired abdominal hernia * Patients after Cesarean section delivery

Design outcomes

Primary

MeasureTime frameDescription
Changes in adipose and muscle tissue measured via ultrasound imaging7 monthsTo determine the effectiveness of the device for strengthening and toning of arms, lower limbs and oblique muscles through changes in surrounding tissues, measured via ultrasound imaging. Using the obtained images, change in adipose and muscular tissues before and after the therapy sessions will be compared for every participant according to the study phase.

Secondary

MeasureTime frameDescription
Patient's satisfaction measured via questionnaires7 monthsTo determine the patient's satisfaction with study treatment for non-invasive strengthening and toning of arms, lower limbs and oblique muscles.The 5-point Likert scale Satisfaction questionnaire will be used to evaluate the participant's satisfaction with the therapy outcome where the level of agreement between strongly agree and strongly disagree should indicate the participant's satisfaction with the therapy.
Incidence Of Treatment-Related Adverse Events7 monthsTo determine side effects and adverse events (AE) associated with the BTL 799-2 treatment of the arms, lower limbs and oblique muscles. Safety outcomes will include an evaluation of the treatment area to assess and evaluate the following: * Muscle pain * Temporary muscle spasm * Temporary joint or tendon pain * Local erythema or skin redness

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026